Peregrine Capital Management LLC Adma Biologics, Inc. Transaction History
Peregrine Capital Management LLC
- $3.18 Billion
- Q4 2024
A detailed history of Peregrine Capital Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Peregrine Capital Management LLC holds 436,197 shares of ADMA stock, worth $7.25 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
436,197
Previous 420,774
3.67%
Holding current value
$7.25 Million
Previous $8.41 Million
11.07%
% of portfolio
0.24%
Previous 0.26%
Shares
7 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$310 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$302 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$247 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$188 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$91.9 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.26B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...